← Back
$ALNY All transactions

ALNYLAM PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

7,763

Price

$0

Filed

Jul 2

Insider

Name

Fitzgerald Kevin Joseph

Title

CSO & EVP, Head of Research

CIK

0001886431

Roles

Officer

Transaction Details

Transaction Date

2025-07-01

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

21,264

Footnotes

These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date. | Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.

Filing Info

Accession No.

0001735276-25-000077

Form Type

4

Issuer CIK

0001178670

Fitzgerald Kevin Joseph's History

Date Ticker Type Value
2026-04-07 OVID A $45K
2026-03-05 ALNY $40K
2026-03-05 ALNY $75K
2026-03-05 ALNY $48K
2026-03-05 ALNY $50K
2026-03-04 ALNY $9K
2026-03-04 ALNY $9K
2026-03-04 ALNY $19K
2026-03-04 ALNY $25K
2026-03-04 ALNY $31K

Other Insiders at ALNY (90d)

Insider Bought Sold Last
Greenstreet Yvonne
Chief Executive Officer
$5.3M 2026-03-04
SUPRAN BRYAN
EVP, CLO and Secretary
2026-03-02
Poulton Jeffrey V.
EVP, Chief Financial Officer
$2.2M 2026-03-04
Garg Pushkal
EVP Chief R&D
$4.9M 2026-03-05
Tanguler Tolga
EVP, Chief Commercial Officer
$1.9M 2026-03-04
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
$2.8M 2026-03-05
McLaughlin Melissa
Chief Human Resources Officer
$1.3M 2026-04-06